CoreWeave Insider Sold Shares Worth $29,684,912, According to a Recent SEC Filing-February 2024-www.financetom.com

CoreWeave Insider Sold Shares Worth $29,684,912, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

CoreWeave Insider Sold Shares Worth $29,684,912, According to a Recent SEC Filing

Sep 2, 2025 12:41 AM

03:23 AM EDT, 09/02/2025 (MT Newswires) -- Kristen J McVeety, General Counsel and Secretary, on August 27, 2025, sold 311,796 shares in CoreWeave ( CRWV ) for $29,684,912. Following the Form 4 filing with the SEC, McVeety has control over a total of 95,000 Class A common shares of the company, with 95,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1769628/000141588925023329/xslF345X05/form4-08302025_120801.xml

Previous page： Redwire Plans to Appoint Chris Edmunds as Chief Financial Officer Next page： Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Redwire Plans to Appoint Chris Edmunds as Chief Financial Officer

Oct 7, 2025

08:17 AM EDT, 10/07/2025 (MT Newswires) -- Redwire ( RDW ) said Tuesday it intends to appoint Chris Edmunds as chief financial officer, replacing Jonathan Baliff, who will retire, effective Nov. 30. Edmunds currently serves as the company's chief accounting officer. Baliff will serve as a consultant through December 2026, Redwire ( RDW ) said. The company's shares were up...

Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models

Oct 7, 2025

08:17 AM EDT, 10/07/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Tuesday that preclinical results show that its investigational therapy Telomir-1 reactivated two tumor suppressor genes, potentially preventing the spread of cancer and improving responses to chemotherapy. The results showed that the experimental therapy reactivated the MASPIN and RASSF1A genes through DNA methylation reset in prostate cancer models,...

IonQ Closes Vector Atomic Acquisition

Oct 7, 2025

08:13 AM EDT, 10/07/2025 (MT Newswires) -- IonQ ( IONQ ) said Tuesday it closed its acquisition of California-based quantum sensing company Vector Atomic. The company said the all-stock deal adds precision atomic clocks, inertial sensors, and synchronization hardware to its computing and networking stack. IonQ ( IONQ ) shares were up over 2% in recent premarket activity. ...

Fractyl Health Says Obesity Drug Candidate Shows Weight Loss in Preclinical Trial

Oct 7, 2025

08:17 AM EDT, 10/07/2025 (MT Newswires) -- Fractyl Health ( GUTS ) said Tuesday that new preclinical data from its obesity candidate RJVA-002 showed 30% weight loss in mice after a single dose, with no adverse effects observed. The company said the study used a diet-induced obesity model with humanized GIP receptors and demonstrated a dose-dependent reduction in body weight...